KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Financing Activities (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Cash from Financing Activities data on record, last reported at -$51.9 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 31.65% year-over-year to -$51.9 million; the TTM value through Dec 2025 reached -$536.7 million, up 2.58%, while the annual FY2025 figure was -$536.7 million, 2.58% up from the prior year.
  • Cash from Financing Activities reached -$51.9 million in Q4 2025 per CRL's latest filing, up from -$152.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $518.0 million in Q2 2021 and bottomed at -$285.9 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is -$27.1 million, with a median of -$61.7 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: soared 597.57% in 2021, then crashed 674.1% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$219.0 million in 2021, then dropped by 13.69% to -$249.0 million in 2022, then skyrocketed by 149.63% to $123.6 million in 2023, then crashed by 161.41% to -$75.9 million in 2024, then soared by 31.65% to -$51.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$51.9 million in Q4 2025, -$152.6 million in Q3 2025, and -$226.9 million in Q2 2025.